Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice

scientific article

Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1742-7843.2008.00268.X
P698PubMed publication ID18684227
P5875ResearchGate publication ID23153181

P2093author name stringWei Chen
Song Li
Li-Li Wang
Hong-Ying Liu
Long Long
P433issue3
P921main subjectmetabolic syndromeQ657193
insulin resistanceQ1053470
dyslipidemiaQ66291209
preproinsulinQ7240673
P304page(s)240-246
P577publication date2008-07-18
P1433published inBasic and Clinical Pharmacology and ToxicologyQ15724438
P1476titlePeroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice
P478volume103

Reverse relations

cites work (P2860)
Q35574757A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice
Q38254275Activation of PPARδ: from computer modelling to biological effects.
Q37075502Assessment of monosodium glutamate (MSG) intake in a rural Thai community: questioning the methodological approach
Q36688852Commentary on: "Further studies are necessary in order to conclude a causal association between the consumption of monosodium L-glutamate (MSG) and the prevalence of the metabolic syndrome in the rural Thai population".
Q36176775Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
Q33808884Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets.
Q34650930Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats
Q97424266Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit
Q37656075Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene
Q37290383P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Q55049564Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.
Q79777537Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
Q38640842Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.
Q34469086Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.

Search more.